As shown in Figure 1A, there is a significant reduction in the expression of ENPP1, ENPP2, ENPP3, and NT5E in the blood of patients with severe COVID-19 when compared to HDs and a lower expression of ENPP2 and ENPP3 when compared to mild hospitalized cases. Here, ENPP1 is linked to COVID-19.